EVALUATION OF JAUNDICE IN ED

 


 



Jaundice is the yellow discoloration of body tissues caused by an excess accumulation of bilirubin, also referred to as hyperbilirubinemia. 

Normal bilirubin levels are less than 1mg/dL, while scleral icterus, a sign of jaundice, is observed when levels exceed 3mg/dL.

 Jaundice is classified into two main types.

1.       Unconjugated hyperbilirubinemia 

2.       Conjugated hyperbilirubinemia

Forms of Bilirubin

Characteristics

Unconjugated

- Insoluble in water.

- Travels in the bloodstream bound to albumin.

- Cannot be directly excreted from the body.

Conjugated

- Water-soluble.

- Travels freely in the bloodstream.

- Excreted in bile and urine


      Pathophysiology of jaundice

  • metabolism of bilirubin occurs in 3 phases.
  1. Prehepatic phase
  2. Hepatic phase
  3. Post hepatic phase.

1.       

2.       





Conjugated Hyperbilirubinemia

Unconjugated Hyperbilirubinemia

Defects in canalicular transport

Dubin-Johnson syndrome

 

 

   ·       Excess production of bilirubin Haemolytic anaemias

   ·       Dyserythropoiesis

   ·       Extravasation of blood into tissues)

Defects in sinusoidal reuptake

Rotor Syndrome

Reduced hepatic uptake.

   ·       Gilbert syndrome

   ·       Heart failure

   ·       Portosystemic shunts

   ·       Certain drugs - Rifampin, probenecid, flavaspadic acid, bunamiodyl

 Intrahepatic Cholestasis
·       Viral hepatitis (A, B, D, EBV, CMV, HSV)
·       Wilson
·       Autoimmune
·       Alcoholic hepatitis, cirrhosis
·       Non-alcoholic steatohepatitis
·       Primary biliary cholangitis, Primary sclerosing cholangitis
·       Infiltrative diseases (amyloidosis, lymphoma, sarcoidosis, tuberculosis)
·       Pregnancy
·       Sepsis and hypoperfusion states, Total parenteral nutrition
·       Drugs and toxins (eg, alkylated steroids, chlorpromazine, herbal medications, arsenic)
·       Hepatic crisis in sickle cell disease
 

Impaired conjugation
 
    ·       Crigler–Najjar syndrome
    ·       Gilbert syndrome
    ·        Hyperthyroidism
    ·       Oestradiol /Oestrogen
    ·       Neonates
    ·       Liver Diseases- Cirrhosis

Extrahepatic cholestasis
·       Choledocholithiasis
·       Tumours (cholangiocarcinoma, pancreatic cancer)
·       Pancreatitis
·       Strictures
·       Parasitic infections like Ascaris, liver flukes





































































In ED emergency evaluation is usually not required except for the following three conditions which are life threating and require early identification and treatment.



Jaundice – Medical Emergencies

Massive Haemolysis

Clostridium perfringens sepsis or falciparum malaria

Ascending Cholangitis

That can lead to sepsis and liver abscesses if not treated promptly. It often requires emergency antibiotic treatment and sometimes surgical intervention.

Fulminant Hepatic Failure

A rapid deterioration of liver function, typically associated with encephalopathy and coagulopathy. It is a life-threatening condition that requires immediate medical attention, often in an intensive care unit.

Diagnostic Approach

diagnosis of jaundice is based on- 

1.Focused History

2.Physical examination

3.Laboratory Evaluation


Focused History


History Information

Possible diagnosis

Use of medications, herbal medications, dietary supplements, recreational drugs

     ·        Drug-induced hyperbilirubinemia

Hepatitis risk factors

     ·        Viral hepatitis

History of abdominal operations

     ·        Post-surgical complications

Inherited disorders                                  

    ·        Genetic liver diseases

HIV status

    ·        HIV-associated liver disease

Exposure to toxic substances

    ·        Toxic liver injury

Development/worsening of jaundice during stress

    ·        Gilbert syndrome

Fever with chills or right upper quadrant pain

    ·        Acute cholangitis

Anorexia, malaise, myalgias

    ·        Viral hepatitis

Right upper quadrant pain

    ·        Extrahepatic biliary obstruction

Acholic stool (Clay coloured stool) 

    ·        Biliary obstruction

    ·        Although rare, it can also be seen in the acute cholestatic phase of viral hepatitis 










































Physical examination



Physical Examination Finding

Potential Implication

Courvoisier sign (palpable gallbladder)

Obstruction distal to the cystic duct, often due to malignancy

Ascites

Chronic liver failure or portal hypertension

Splenomegaly

Portal hypertension or other hematologic conditions

Spider angiomata

Chronic liver disease

Gynecomastia

Hormonal imbalance often associated with liver disease

Hyperpigmentation

Hemochromatosis

Kayser-Fleischer rings

Wilson disease

Xanthomas

Primary biliary cholangitis


































3 Laboratory Evaluation

 

·       Serum total and unconjugated bilirubin
·       Alkaline phosphatase
·       Aminotransferases (aspartate aminotransferase [AST] and alanine aminotransferase [ALT])
·       Prothrombin time/international normalized ratio (INR) – acute liver function
·       Albumin – chronic liver function
·       Urine Bilirubin

·       Hepatocellular workup: viral serologies, autoimmune antibodies, serum ceruloplasmin, ferritin.

      Cholestatic workup: Additional tests include abdominal ultrasound, CT, magnetic resonance cholangiopancreatography (MRCP), endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), endoscopic ultrasound (EUS).

 

Interpretations


TestInterpretation
AST (Aspartate Aminotransferase)- Less specific to the liver than ALT
- Non-hepatic sources: Skeletal muscle, Cardiac muscle, RBC, Brain, Kidney.
ALT (Alanine Aminotransferase)- More specific to the liver than AST.
- Non-hepatic sources: Skeletal muscle, Cardiac muscle, Kidney.
GGT (Gamma-Glutamyl Transferase)- Specific to the liver.
- Assists in liver specificity when combined with ALP.
AST/ALT Ratio- AST/ALT > 2: Alcoholic hepatitis
- AST/ALT < 1: NASH or Cirrhosis.
- AST/ALT > 3: Acute muscle injury.
ALP (Alkaline Phosphatase)- ALP > AST/ALT: Suggestive of cholestatic disease.
- ALP elevation with Normal GGT and 5-Nucleotidase rules out hepatic causes.
- ALP elevation with normal AST/ALT: Indicates infiltrative diseases.
Unconjugated Bilirubin- If >90% of total bilirubin: Hemolysis or Gilbert’s syndrome.
AST and ALT values in 1000s- Hepatocellular disease likely due to toxins (e.g., acetaminophen), ischemia, or viral infections.
Normal AST, ALT, and ALP- Pre-hepatic causes: Inherited disorders of liver conjugation, blood disorders
- Defects in hepatic excretion (e.g., Rotor syndrome, Dubin-Johnson syndrome).


 

R value 

 

The R value is a ratio used to interpret liver function tests, particularly in the context of liver injury.

It compares the levels of alanine aminotransferase (ALT) and alkaline phosphatase (ALP) against their respective upper limits of normal (ULN).

 

Here’s how you can represent the R value formula:


This formula helps in differentiating between hepatocellular injury and cholestatic or obstructive patterns of liver disease.

 






·       R > 5 - suggests hepatocellular damage

·       R < 2 - suggests cholestatic or obstructive damage.

·       R 2-5 - may require further investigation or could be indicative of mixed liver injury.

 Remember to use the patient’s specific lab values and ULN for accurate calculation and interpretation.


Jaundice evaluation in ED


Remember that ALP is elevated not only in Obstructive jaundice it can also occur with intra hepatic cholestasis. The following flow chart helps in differentiate various causes of raised ALP.


Also moderate elevation of AST /ALT is not always due to Liver injury. AST ALT is not 100% specific to Liver as I discussed above the condtions with moderate elevation of AST/ALT are the following

1.Thyroid Disorders

2. Myocardial Infarction

3. Adrenal insufficiency

4. Muscle Injuries (as in Strenous exercise / Myopathy) 

5. Anorexia Nervosa / Celiac Disease


References

1.Guerra Ruiz AR, Crespo J, López Martínez RM, Iruzubieta P, Casals Mercadal G, Lalana Garcés M, Lavin B, Morales Ruiz M. Measurement and clinical usefulness of bilirubin in liver disease. Advances in Laboratory Medicine/Avances en Medicina de Laboratorio. 2021 Aug 4;2(3):352-61.

2.Uptodate -Evaluation of Jaundice

3.Schwarzenbach HR. [Jaundice and pathological liver values]. Praxis (Bern 1994). 2013 Jun  05;102(12):727-9. [PubMed]
4.
Leung TS, Outlaw F, MacDonald LW, Meek J. Jaundice Eye Color Index (JECI): quantifying the yellowness of the sclera in jaundiced neonates with digital photography. Biomed Opt Express. 2019 Mar 01;10(3):1250-1256. [PMC free article] [PubMed]
5.
Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004 Jan


 

Comments

Popular posts from this blog

Pediatric Procedural Sedation And Analgesia